Laird Miers

2.4k total citations
41 papers, 1.9k citations indexed

About

Laird Miers is a scholar working on Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Laird Miers has authored 41 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Radiology, Nuclear Medicine and Imaging, 13 papers in Pathology and Forensic Medicine and 12 papers in Molecular Biology. Recurrent topics in Laird Miers's work include Radiopharmaceutical Chemistry and Applications (23 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Lung Cancer Treatments and Mutations (8 papers). Laird Miers is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (23 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Lung Cancer Treatments and Mutations (8 papers). Laird Miers collaborates with scholars based in United States, Italy and South Korea. Laird Miers's co-authors include Sally J. DeNardo, Gerald L. DeNardo, David Pleasure, Kathleen R. Lamborn, David L. Kukis, Peter Bannerman, Fuzheng Guo, Athena M. Soulika, Claude F. Meares and Arutselvan Natarajan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Blood.

In The Last Decade

Laird Miers

41 papers receiving 1.9k citations

Peers

Laird Miers
Ricardo F. Frausto United States
Shin‐Ichi Miyatake Japan
Helen L. Fillmore United States
Elaine Jordan United States
Linda Chaabane Italy
Douglas W. Laske United States
Gino B. Ferraro United States
Paula J. Foster Canada
Christilyn Graff United States
Susann M. Brady‐Kalnay United States
Ricardo F. Frausto United States
Laird Miers
Citations per year, relative to Laird Miers Laird Miers (= 1×) peers Ricardo F. Frausto

Countries citing papers authored by Laird Miers

Since Specialization
Citations

This map shows the geographic impact of Laird Miers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laird Miers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laird Miers more than expected).

Fields of papers citing papers by Laird Miers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laird Miers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laird Miers. The network helps show where Laird Miers may publish in the future.

Co-authorship network of co-authors of Laird Miers

This figure shows the co-authorship network connecting the top 25 collaborators of Laird Miers. A scholar is included among the top collaborators of Laird Miers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laird Miers. Laird Miers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sohn, Jiho, Peter Bannerman, Fuzheng Guo, et al.. (2016). SuppressingN-Acetyl-l-Aspartate Synthesis Prevents Loss of Neurons in a Murine Model of Canavan Leukodystrophy. Journal of Neuroscience. 37(2). 413–421. 19 indexed citations
2.
Bannerman, Peter, Travis Burns, Jie Xu, Laird Miers, & David Pleasure. (2016). Mice Hemizygous for a Pathogenic Mitofusin-2 Allele Exhibit Hind Limb/Foot Gait Deficits and Phenotypic Perturbations in Nerve and Muscle. PLoS ONE. 11(12). e0167573–e0167573. 32 indexed citations
3.
Burns, Travis, et al.. (2015). Therapeutic depletion of monocyte-derived cells protects from long-term axonal loss in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 290. 36–46. 27 indexed citations
4.
Moreno, Margarita, Peter Bannerman, Joyce Ma, et al.. (2014). Conditional Ablation of Astroglial CCL2 Suppresses CNS Accumulation of M1 Macrophages and Preserves Axons in Mice with MOG Peptide EAE. Journal of Neuroscience. 34(24). 8175–8185. 97 indexed citations
5.
Burns, Travis, Laird Miers, Jie Xu, et al.. (2014). Neuronopathy in the Motor Neocortex in a Chronic Model of Multiple Sclerosis. Journal of Neuropathology & Experimental Neurology. 73(4). 335–344. 8 indexed citations
6.
Ko, Emily Mills, Helena Joyce, Fuzheng Guo, et al.. (2014). Deletion of astroglial CXCL10 delays clinical onset but does not affect progressive axon loss in a murine autoimmune multiple sclerosis model. Journal of Neuroinflammation. 11(1). 105–105. 70 indexed citations
7.
Guo, Fuzheng, Yoshiko Maeda, Joyce Ma, et al.. (2010). Pyramidal Neurons Are Generated from Oligodendroglial Progenitor Cells in Adult Piriform Cortex. Journal of Neuroscience. 30(36). 12036–12049. 146 indexed citations
8.
Soulika, Athena M., et al.. (2009). Initiation and Progression of Axonopathy in Experimental Autoimmune Encephalomyelitis. Journal of Neuroscience. 29(47). 14965–14979. 118 indexed citations
9.
DeNardo, Gerald L., Arutselvan Natarajan, Saphon Hok, et al.. (2007). Pharmacokinetic Characterization in Xenografted Mice of a Series of First-Generation Mimics for HLA-DR Antibody, Lym-1, as Carrier Molecules to Image and Treat Lymphoma. Journal of Nuclear Medicine. 48(8). 1338–1347. 74 indexed citations
10.
DeNardo, Gerald L., Sally J. DeNardo, Jim Peterson, et al.. (2003). Preclinical evaluation of cathepsin-degradable peptide linkers for radioimmunoconjugates.. PubMed. 9(10 Pt 2). 3865S–72S. 12 indexed citations
11.
Burke, Peter, Sally J. DeNardo, Laird Miers, et al.. (2002). Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts.. PubMed. 62(15). 4263–72. 181 indexed citations
12.
Burke, Peter, Sally J. DeNardo, Laird Miers, David L. Kukis, & Gerald L. DeNardo. (2002). Combined modality radioimmunotherapy. Cancer. 94(S4). 1320–1331. 35 indexed citations
13.
OʼDonnell, Robert T., Sally J. DeNardo, Laird Miers, et al.. (2001). Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium‐DOTA‐peptide‐ChL6. The Prostate. 50(1). 27–37. 47 indexed citations
14.
DeNardo, Sally J., Peter Burke, Bryan R. Leigh, et al.. (2000). Neovascular Targeting with Cyclic RGD Peptide (cRGDf-ACHA) to Enhance Delivery of Radioimmunotherapy. Cancer Biotherapy and Radiopharmaceuticals. 15(1). 71–79. 44 indexed citations
15.
OʼDonnell, Robert T., Sally J. DeNardo, Gerald L. DeNardo, et al.. (2000). Efficacy and toxicity of radioimmunotherapy with90Y-DOTA-peptide-ChL6 for PC3-tumored mice. The Prostate. 44(3). 187–192. 5 indexed citations
16.
Leigh, Bryan R., Peter Burke, Angela Hong, et al.. (1999). Preclinical Evaluation of Chimeric L6 Antibody for the Treatment of Kaposi's Sarcoma with Radioimmunotherapy. Cancer Biotherapy and Radiopharmaceuticals. 14(2). 113–119. 2 indexed citations
17.
OʼDonnell, Robert T., Sally J. DeNardo, Laird Miers, et al.. (1998). Combined Modality Radioimmunotherapy with Taxol and 90 Y-LYM-1 for Raji Lymphoma Xenografts. Cancer Biotherapy and Radiopharmaceuticals. 13(5). 351–361. 28 indexed citations
18.
DeNardo, Gerald L., David L. Kukis, Sally J. DeNardo, et al.. (1997). Enhancement of67Cu-2IT-BAT-LYM-1 therapy in mice with human burkitt's lymphoma (Raji) using interleukin-2. Cancer. 80(S12). 2576–2582. 8 indexed citations
19.
Meares, Claude F., et al.. (1995). Prelabeling of chimeric monoclonal antibody L6 with 90yttrium- and 111indium-1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA) chelates for radioimmunodiagnosis and therapy.. PubMed. 55(23 Suppl). 5726s–5728s. 10 indexed citations
20.
Li, Man, et al.. (1994). Labeling Monoclonal Antibodies with 90Yttrium- and 111Indium-DOTA Chelates: A Simple and Efficient Method. Bioconjugate Chemistry. 5(2). 101–104. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ricardo F. Frausto Breakdown of academic impact, for papers by Shin‐Ichi Miyatake Breakdown of academic impact, for papers by Helen L. Fillmore Breakdown of academic impact, for papers by Elaine Jordan Breakdown of academic impact, for papers by Linda Chaabane Breakdown of academic impact, for papers by Douglas W. Laske Breakdown of academic impact, for papers by Gino B. Ferraro Breakdown of academic impact, for papers by Paula J. Foster Breakdown of academic impact, for papers by Christilyn Graff Breakdown of academic impact, for papers by Susann M. Brady‐Kalnay
Rankless by CCL
2026